To further validate the role of IFNγ signaling in AML cell survival and drug resistance, we isolated leukemic blasts from primary patient samples (n = 3 patients) and cultured them in the absence or presence of IFN-γ, and with increasing concentrations of venetoclax then assessed the AML cell viability. The gene discussed is IFNG; the disease is acute myeloid leukemia.